CHINA FINANCE ONLINE CO-ADR (JRJC)

ADR

3.99  -2.45 (-38.04%)

After market: 4.15 +0.16 (+4.01%)

Fundamental Rating

1

JRJC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 210 industry peers in the Capital Markets industry. JRJC has a bad profitability rating. Also its financial health evaluation is rather negative. JRJC has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

JRJC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -14.95%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -28%
PM (TTM) -26.5%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

The number of shares outstanding for JRJC remains at a similar level compared to 1 year ago.
Compared to 1 year ago, JRJC has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.09 indicates that JRJC is not in any danger for bankruptcy at the moment.
JRJC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 6.09
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

JRJC has a Current Ratio of 0.91. This is a bad value and indicates that JRJC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.91 indicates that JRJC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.52% over the past year.
Measured over the past years, JRJC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -67.27% on average per year.
The Revenue has grown by 12.68% in the past year. This is quite good.
JRJC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -17.92% yearly.
EPS 1Y (TTM)6.52%
EPS 3Y-67.27%
EPS 5YN/A
EPS growth Q2Q-238.92%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y-2.08%
Revenue growth 5Y-17.92%
Revenue growth Q2Q51.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

JRJC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.54

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JRJC!.
Industry RankSector Rank
Dividend Yield N/A

CHINA FINANCE ONLINE CO-ADR

NASDAQ:JRJC (1/20/2022, 7:18:38 PM)

After market: 4.15 +0.16 (+4.01%)

3.99

-2.45 (-38.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.74M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.95%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -28%
PM (TTM) -26.5%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.52%
EPS 3Y-67.27%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.68%
Revenue growth 3Y-2.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y